Search clinical trials for: Neupogen (filgrastim)

Total 1135 results

M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer

Breast Cancer

United States
National Cancer Institute (NCI)

Terminated

Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone... and other conditions

United States
Washington University School of Medicine

Completed

Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia

Leukemia, Myeloid, Acute

United States
Recardio, Inc.

Not yet recruiting

Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction (HEAL-MI)

ST Elevation Myocardial Infarction
M.D. Anderson Cancer Center
Amgen

Terminated

Tissue Repair in Stem Cell Transplant Recipients

Graft-Versus-Host Disease

United States
National University Hospital, Singapore

Not yet recruiting

A Biomarker-implemented Clinical Study Evaluating Mutations in MET and TP53 in a Population of Treatment-refractory Squamous Cell Carcinoma

Squamous Cell Carcinoma

Singapore
National Institute of Allergy and Infectious Diseases...

Recruiting

Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Idiopathic CD4-Positive | T-Lymphocytopenia

United States
Yale University
National Cancer Institute (NCI)

Completed

Aminocamptothecin in Treating Patients With T-cell Lymphoma

Lymphoma

United States
Armando Santoro, MD

Completed

Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy

Tumors | Hematological Neoplasms

Italy
AviGenics

Completed

Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia

Breast Cancer | Neutropenia

United States, India
Blau Farmaceutica S.A.

Not yet recruiting

Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy

Breast Cancer
Cinnagen

Completed

Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FN

Chemotherapy-induced Neutropenia
University of Pisa

Unknown

Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple Myeloma

G-CSF, Multiple Myeloma, Febrile Episode, Filgrastim, Leograstim
St. Jude Children's Research Hospital

Completed

Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome

Severe Combined Immunodeficiency

United States
Medical College of Wisconsin

Recruiting

Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)

Acute Myeloid Leukemia | Myelodysplastic Syndrome

United States
Maria Sklodowska-Curie National Research Institute...

Unknown

Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma

Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma

Poland
Ministry of Health, Brazil
Financiadora de Estudos e Projetos

Terminated

Cell Therapy in Chagas Cardiomyopathy

Chagas Cardiomyopathy

Brazil
Paul Szabolcs

Recruiting

Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis (SSc)

Systemic Sclerosis | Pulmonary Hypertension | Interstitial Lung Disease | Diffuse Sclerosis Systemic

United States
Northwestern University

Withdrawn

Autologous Transplant Targeted Against Crohn's (ATTAC)

Crohn's Disease

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy

Unspecified Childhood Solid Tumor, Protocol Specific | Neutropenia | Fever, Sweats, and Hot Flashes

United States, Canada, Puerto Rico, Australia, Netherlands, New Zealand, Switzerland
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy Participants (GRANIX)

Healthy Participants

United States
Hospital Universitari Vall d'Hebron Research Institute
CIEMAT; CIBERER

Completed

Clinical Phase II Trial to Evaluate CD34+ Cells Mobilization and Collection in Patients With Fanconi Anemia for Subsequent Transduction With a Lentiviral Vector Carring FANCA Gene. FANCOSTEM-1

Fanconi Anemia

Spain
Megalabs

Not yet recruiting

Biosimilarity Study of Subcutaneous Filgrastim in Healthy Volunteers

Healthy
Baylor Health Care System
National Cancer Institute (NCI)

Unknown

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Terminated

Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery

Uterine Corpus Leiomyosarcoma | Stage I Uterine Sarcoma AJCC v7

United States, Belgium, France, Spain, United Kingdom, Netherlands, Norway, Venezuela
Memorial Sloan Kettering Cancer Center

Completed

Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor

Hematologic Malignancy

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors

Neuroblastoma | Brain Tumors | Central Nervous System Tumors

United States, Australia, Canada
National Cancer Institute (NCI)

Active, not recruiting

Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

Ann Arbor Stage III Hodgkin Lymphoma | Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma | Ann Arbor Stage III Mixed Cellularity Classic Hodgkin Lymphoma | Ann Arbor Stage III Nodular Sclerosis Classic Hodgkin Lymphoma | Ann Arbor Stage IV Hodgkin Lymphoma | Ann Arbor Stage IV... and other conditions

United States, Canada, Puerto Rico
M.D. Anderson Cancer Center
Cancer Cures 4 Kids

Recruiting

Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma

Angiosarcoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Systemic Chemotherapy and Subtenon Carboplatin, and Local Ophthalmic Therapy in Children With Intraocular Retinoblastoma

Intraocular Retinoblastoma

United States
Therapeutic Advances in Childhood Leukemia Consortium
Genzyme, a Sanofi Company

Terminated

T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML)

Relapsed Acute Myelogenous Leukemia

United States
Rafic Farah, MD

Completed

Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source

Lymphoma | Leukemia | Myelofibrosis | MDS

United States
Stephen Couban
Genzyme, a Sanofi Company

Completed

Healthy Donor Study II - Comparing Plerixafor With G-CSF and Plerixafor

Malignant Lymphoma, Stem Cell Type

Canada
St. Jude Children's Research Hospital

Recruiting

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

Rhabdomyosarcoma

United States
MinYoung Kim, M.D.

Completed

Combination Therapy of Cord Blood and G-CSF for Patients With Brain Injury or Neurodegenerative Disorders

Cerebral Palsy | Parkinson's Disease | Brain Injury | Amyotrophic Lateral Sclerosis

Korea, Republic of
Fred Hutchinson Cancer Center

Completed

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

Sarcoma | Lymphoma | Kidney Cancer | Myelodysplastic Syndromes | Leukemia | Neuroblastoma

United States
Xiamen Amoytop Biotech Co., Ltd.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of YPEG-Filgrastim in Chemotherapy Patients (Filgrastim)

Chemotherapy Patients

China
Cairo University

Recruiting

Intrauterine Infusion of GCSF and Reproductive Outcomes in Infertile Women With History of RIF

Infertility | Recurrent Implantation Failure | Granulocyte Colony-Stimulating Factor

Egypt
Eli Lilly and Company

Completed

A Study of LY2523355 in Participants With Breast Cancer

Metastatic Breast Cancer

United States
Sygnis Bioscience GmbH & Co KG

Completed

AXIS 2: AX200 for the Treatment of Ischemic Stroke (AXIS-2)

Acute Ischemic Stroke

Spain, Belgium, Germany, Slovakia, Austria, Czech Republic, Poland
Centre Leon Berard
Amgen

Completed

Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma (PALM)

Lymphoma | Myeloma

France
Washington University School of Medicine

Completed

Granulocyte Colony-stimulating Factor (G-CSF) Plus or Minus AMD3100 for Engraftment Post Allogeneic Transplant

Stem Cell Transplant Patients

United States
Children's Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET

Medulloblastoma | Anaplastic Medulloblastoma

United States, Canada, Puerto Rico, Australia, Netherlands
Children's Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

Ependymoma | Anaplastic Ependymoma | Clear Cell Ependymoma | Brain Ependymoma | Cellular Ependymoma | Papillary Ependymoma

United States, Canada, Australia, New Zealand
National Cancer Institute (NCI)

Completed

Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer

Inflammatory Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer

United States
The Canadian College of Naturopathic Medicine
Queen Elizabeth II Health Sciences Centre

Withdrawn

Neuragen for Peripheral Diabetic Neuropathy

Diabetic Peripheral Neuropathy | Diabetic Neuralgia

Canada
Sun Yat-sen University
JIANGSU JIBEIER PHARMACEUTICAL CO.,LTD

Not yet recruiting

A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC

Nasopharyngeal Carcinoma | Chemotherapy | Myelosuppression | Leucogen

China
National Cancer Institute (NCI)

Completed

Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma

United States
Michael Hopp
Boehringer Ingelheim

Active, not recruiting

AFAMOSI: Efficacy and Safety of Afatinib Followed by Osimertinib Compared to Osimertinib in Patients With EGFRmutated/T790M Mutation Negative Nonsquamous NSCLC

Non-squamous NSCLC

Germany
Amgen

Completed

Treatment for Subjects With Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

Search clinical trials for: Neupogen (filgrastim)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations